Health & Medicine

6
facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194May 1, 2014

Penn Vet Research Identifies Compounds That Control Hemorrhagic Viruses

blurb: 
Researchers at the University of Pennsylvania School of Veterinary Medicine teamed with colleagues to identify and develop compounds that could reduce the ability of viruses that cause diseases such as Ebola, rabies, HIV and Lassa fever to spread infection.

People fear diseases such as Ebola, Marburg, Lassa fever, rabies and HIV for good reason; they have high mortality rates and few, if any, possible treatments. As many as 90 percent of people who contract Ebola, for instance, die of the disease.

Mercy Douglass School of Nursing Remembered, Honored

April 28, 2014

Loretta Sweet Jemmott of the School of Nursing talks about her time as a candy striper at the local hospital.

Article Source: Philadelphia Tribune

Cloning Used to Make Stem Cells From Adult Humans

April 28, 2014

John Gearhart of the Perelman School of Medicine comments on using cloning technologies to generate stem cells.

Article Source: CNN

Neurology Report Mixed on Benefits of Medical Pot

April 28, 2014

Clyde Markowitz of the Perelman School of Medicine talks about his reservations about the side effects and long-term consequences of medical marijuana.

Article Source: Philadelphia Inquirer
facebook twitter google print email
Media Contact:Kim Menard | Kim.Menard@uphs.upenn.edu | 215-662-6183April 28, 2014

Penn Medicine Stroke Experts Identify Geographic and Gender Disparities Among Stroke Patients, Demonstrate New App to Optimize Acute Stroke Care

Stroke researchers from the Perelman School of Medicine at the University of Pennsylvania will unveil a map demonstrating geographic hotspots of increased stroke mortality across the United States, among a series of stroke studies being presented at the American Academy of Neurology’s 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

facebook twitter google print email
Media Contact:Katie Delach | Katie.Delach@uphs.upenn.edu | 215-349-5964April 25, 2014

Attacking Cancer Indirectly: Penn Researchers Generate Immunity Against Tumor Vessel Protein

Sometimes a full-on assault isn't the best approach when dealing with a powerful enemy. A more effective approach, in the long run, may be to target the support system replenishing the supplies that keep your foe strong and ready for battle.

In Health Care, Lessons for Obama on Rating Colleges

April 21, 2014

Rachel Werner of the Perelman School of Medicine shares her comments on the usefulness of Nursing Home Compare.

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660April 18, 2014

Penn Medicine: New Treatments Tame Hepatitis C Virus, Lessen Side Effects Seen with Other Therapies

Three million Americans suffer from Hepatitis C Virus (HCV) infection, with baby boomers representing a large proportion of those infected.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658April 24, 2014

Penn Fruitfly Study Identifies Brain Circuit that Drives Daily Cycles of Rest, Activity

Amita Sehgal, PhD, a professor of Neuroscience at the Perelman School of Medicine, University of Pennsylvania, describes in Cell a circuit in the brain of fruit flies that controls their daily, rhythmic behavior of rest and activity.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653April 24, 2014

Penn Medicine Study: Sorafenib Shows Success in Advanced Differentiated Thyroid Cancer Patients

The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania published in the journal Lancet. This is the first effective treatment for thyroid cancer patients who progress following standard treatments.